Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aiTBS and CCT in Treatment Resistant Depression
NCT03288675Completed
- Sponsor
- Ghent University Hospital
- Start
- Oct 2017
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) (4 arms), sponsored by Ghent University Hospital. Primary endpoint: Changes in depression severity - clinician-rated at 6 months. Started Oct 2017; status: completed.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03288675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288675.